LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended March 31, 2023 and raised full-year 2023 guidance. Financial
LivaNova PLC , a market-leading medical technology and innovation company, today reported results for the quarter ended March 31, 2023 and raised full-year 2023 guidance.
Financial Summary and. | May 3, 2023
/PRNewswire/ The "Heart Failure Devices Global Market - Forecast To 2029" report has been added to ResearchAndMarkets.com s offering. The heart failure.